VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer
Status:
Recruiting
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
This is a single arm, open-lable Phase I clinical trial. Eligible patients will have
Histologically proven stage IB2-IVA cervical cancer. We hypothesize that Nab-paclitaxel in
combination with cisplatin and radiotherapy may have anti-tumor activity in patients with
cervical cancer. Nab-paclitaxel has not previously been combined with conventional RT-CT to
treat cervical cancer.